No Data
6 Analysts Assess Amylyx Pharma: What You Need To Know
Across the recent three months, 6 analysts have shared their insights on Amylyx Pharma (NASDAQ:AMLX), expressing a variety of opinions spanning from bullish to bearish.The table below provides a snaps
H.C. Wainwright Maintains Amylyx Pharmaceuticals(AMLX.US) With Buy Rating, Maintains Target Price $8
H.C. Wainwright analyst Andrew Fein maintains $Amylyx Pharmaceuticals(AMLX.US)$ with a buy rating, and maintains the target price at $8.According to TipRanks data, the analyst has a success rate of 47
Amylyx Inks Deal to Buy Eiger's GLP-1 Targeting Drug
ALS Therapy Market Seen Increasing to Nearly $1.3B by 2029
Analysts Conflicted on These Healthcare Names: Iovance Biotherapeutics (IOVA), Amylyx Pharmaceuticals Inc (AMLX) and Vaxcyte (PCVX)
Amylyx Pharmaceuticals(AMLX.US) Director Buys US$9,436.03 in Common Stock
$Amylyx Pharmaceuticals(AMLX.US)$ Director Quimi Daphne purchased 5,000 shares of common stock on May 14, 15, 2024 at an average price of $1.8872 for a total value of $9,436.03.Source: Announcement Wh